Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Apyx Medical Corp (APYX)

Apyx Medical stockholders approve 2026 Share Incentive Plan and elect five directors

Neutral Impact 2 of 5 shareholder Written later

At its August 6, 2026 annual meeting, Apyx Medical stockholders approved the company's 2026 Share Incentive Plan, elected all five director nominees, ratified RSM US LLP as auditor for 2026, and approved a non-binding advisory vote on executive compensation. The filing reports only vote outcomes and does not describe changes to the company's financial results.

Key points

  • 2026 Share Incentive Plan approved with 16,186,776 votes for, 2,755,882 against and 3,276,000 abstaining
  • All five director nominees were elected to serve until the 2027 annual meeting
  • RSM US LLP ratified as independent registered public accounting firm for the year ending December 31, 2026, with 29,814,618 votes in favor
  • Non-binding say-on-pay resolution approved with 21,458,554 votes for and 669,298 against

The filing

CompanyApyx Medical Corp (APYX)
Form8-K, current report
Filed with the SECAug 7, 2026, 4:00 PM ET
Accession number0001493152-26-036557

Items reported: 5.02 Director / Officer Change5.07 Shareholder Vote Results

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:51 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 07, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.